Abeona Therapeutics Inc.ABEONASDAQ

Revenue (LTM)

$6M

Net Income (LTM)

$71M

+211.7% YoY

Free Cash Flow

$-84M

Revenue CAGR (5Y)

-10.3%

Marginsdeclining

FCF($0.1B)

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	3	1↓52.9%	4↑147.5%	0	6
Gross Profit	3	1↓67.9%	2↑96.6%	-3↓253.4%	4↑247.5%
Operating Income	-90	-51↑43.3%	-47↑7.4%	-64↓36.2%	-89↓39.3%
Net Income	-85	-40↑53.3%	-54↓36.5%	-64↓17.6%	71↑211.7%
EBITDA	-77	-34↑55.2%	-51↓47.1%	-57↓12.0%	-86↓51.7%
EPS Diluted	-21.50	-5.53↑74.3%	-2.53↑54.2%	-1.55↑38.7%	1.01↑165.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	33	14↓56.8%	14↑1.8%	23↑61.4%	78↑235.8%
Total Current Assets	56	53↓5.7%	56↑5.0%	101↑80.9%	205↑103.2%
Total Assets	80	64↓19.3%	64↓0.3%	109↑70.2%	220↑101.6%
Total Current Liabilities	17	8↓53.2%	13↑72.5%	17↑23.6%	30↑78.3%
Total Liabilities	37	37↑0.6%	49↑31.3%	65↑32.0%	60↓7.0%
Total Equity	42	27↓36.8%	15↓44.6%	44↑197.0%	159↑261.6%
Total Debt	9	8↓18.7%	5↓29.2%	23↑326.8%	25↑8.3%
Net Debt	-24	-7↑72.0%	-9↓37.7%	-0↑96.6%	-53↓17203.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-66	-43↑33.8%	-37↑14.9%	-56↓51.4%	-76↓36.3%
Capital Expenditure	-4	-0↑96.9%	-0↓154.6%	-2↓639.0%	-8↓226.0%
Free Cash Flow	-70	-44↑37.5%	-37↑14.4%	-58↓56.6%	-84↓44.2%
Stock-Based Comp	9	3↓65.8%	5↑56.3%	7↑39.0%	11↑62.6%
Net Change in Cash	25	-24↓196.1%	0↑101.1%	9↑3370.3%	55↑516.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance